期刊文献+

沉默信息调节因子1促进肝细胞增殖的机制 被引量:1

Mechanism of SIRT1 promoting the proliferation of hepatocytes
下载PDF
导出
摘要 目的:明确沉默信息调节因子1(SIRT1)对肝癌细胞系HepG2细胞生物学功能的影响。方法:构建pCDNA4-SIRT1质粒,合成SIRT1的siRNA,转染肝癌HepG2细胞系。XTT法及CCK-8法检测细胞的增殖活力、流式细胞仪检测细胞周期及细胞凋亡率、Western blot检测蛋白的表达。结果:干扰SIRT1表达均可明显抑制HepG2细胞增殖(P<0.001);干扰SIRT1表达均可明显抑制HepG2细胞S期(P<0.01),而使G1期明显增加(P<0.001);干扰SIRT1表达可明显促进HepG2细胞凋亡(P<0.001);在HepG2细胞中当抑制SIRT1表达时,PTEN的乙酰化水平、磷酸化AKT和PI3K的表达水平明显增加。结论:SIRT1在肝癌细胞系HepG2增殖中起重要作用,同时存在抑制其凋亡的作用,该作用涉及PTEN/PI3K/AKT信号转导通路。 Objective To investigate the effects of SIRT1 on the biological behaviors of liver cancer cell lines HepG2. Methods pCDNA4-SIRT1 plasmid was constructed, and siRNA of SIRT1 was synthesized and transfected into HepG2 cells. The proliferation of HepG2 cells was evaluated by XTr assay and CCK-8 kit; flow cytometry was employed to analyze the distribution of cell cycle and apoptosis rate; and Western blotting was performed to detect the expression of PTEN, PI3K and AKT. Results Down-regulation of SIRT1 could significantly suppress the proliferation of HepG2 cells (P 〈 0.001 ), could decrease the percentage of HepG2 cells in S and G2/M phase (P 〈 0.01 ) while increase the percentage of HepG2 cells in G0/G1 phase (P 〈 0.001), could inhibit the apoptosis of HepG2 cells (P 〈 0.001 ), and could up-regulate the expressions of PTEN, PI3K and AKT. Conclusion SIRT1 played a significant role in the proliferation and apoptosis of HepG2 cells, which was correlated with PTEN/PI3K/AKT signaling pathway.
出处 《实用医学杂志》 CAS 北大核心 2013年第16期2634-2637,共4页 The Journal of Practical Medicine
基金 国家自然科学基金面上项目(编号:81172383) 广东省自然科学基金资助博士启动项目(编号:S2011040002946)
关键词 SIRT1 HEPG2 肝细胞癌 增殖 SIRT1 HepG2 Hepatocellular carcinoma Proliferation
  • 相关文献

参考文献10

  • 1Yamamoto H, Sehoonjans K, Auwerx J. Sirtuin functions in health and disease [J]. Mol Endoerinol , 2007, 21 (8): 1745-1755.
  • 2王汉宁,冯志强,向国安,张洪义,陈开运,肖金丰,贺轲,段小鹏.Sirt1在肝癌及癌旁组织中的表达差异研究[J].中国现代普通外科进展,2012,15(6):421-425. 被引量:2
  • 3Dali-Youcef N, Lagouge M, Froelich S, et al. Sirtuins : the ' mag-nificent seven', function, metabolism and longevity [ J ]. Ann Med, 2007,39(5) :335-345.
  • 4Haigis M C, Sinclair D A. Mammalian sirtuins:biological insights and disease relevance [J]. AnnuRev Pathol ,2010,5: 253-295.
  • 5Oberdoerffer P, Michan S, McVay M, et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging [J]. Cell, 2008,135 (5) :907- 918.
  • 6Herranz D, Munoz-Martin M, Canamero M, et al. Sirtl improves healthy ageing and protects from metabolic syndrome- associated cancer [J]. Nat Commun,2010,1:3-12.
  • 7Vaquero A, Seher M, Erdjument-Bromage H, et al. SIRT1 regulates the histone methyl-transferase SUV39Hlduring heterochromatin formation [ J ]. Nature, 2007,450 (7168) : 440- 444.
  • 8Cheng H L, Mostoslavsky R, Saito S, et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)- deficient mice [J]. Proc Natl Acad Sci U S A ,2003, 100 (19): 10794- 10799.
  • 9Banks A S, Kon N, Knight C, et al. Sirtl gain of function increases energy efficiency and prevents diabetes in mice [J]. Cell Metab ,2008,8(4) : 333-341.
  • 10Firestein R, Blander G, Michan S, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth [Jl. PLoS One,2008,3(4) : e2020.

二级参考文献21

  • 1Yamamorro H, Schoonjans K, Auwerx J. Sirtuin functions in health and disease [J]. Molecular Endocrinology, 2007,21 ( 8 ): 1745-1755.
  • 2Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 [J]. CA Cancer J Clin, 2010,60(5):277-300.
  • 3Espinosa E, Zamora P, Feliu J, et al. Classification of anticancer drugs-a new system based on therapeutic targets[J]. Cancer Treat Rev, 2003,29(6):515-523.
  • 4Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides [J]. BBA-Biomembranes, 2008,1778 (2) :357- 375.
  • 5Janin YL. Peptides with anticancer use or potential[J]. Amino Acids, 2003,25 ( 1 ): 1-4.
  • 6Danielle MW, Chin FT, Yuhua S, et al. O-GlcNAc modifications regulate.cell survival and epib01y during zebrafish development [J]. BMC Developmental Biology, 2009,9(28):1-24.
  • 7Wang HQ, Takahashi R. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease[J]. Antioxid Redox Sigllal, 2007,9(5):553-561.
  • 8Fortini ME. Notch signaling: the core pathway and its posttranslational regulation[J]. Dev Cell, 2009,16 (5) :633-647.
  • 9Dali-Youcef N, Lagouge M, Froelich S, et al. Sirtuins:the 'magnificent seven', function, metabolism and longevity[J]. Ann Med, 2007,39 (5) :335-345.
  • 10Michishita E, McCord RA, Berber E, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin [J]. Nature, 2008, 452:492-496.

共引文献1

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部